Skip to main content
Back

Research and Development Tax Incentive Guidance

Inland Revenue

Funding & Finance
PDF
Inland Revenue
Published April 2026
Authority5/5Freshness5/5Relevance4/5KB value5/5
Evidence class

Sector evidence

Sector body

Reviewed

10 August 2026

Next review not yet scheduled

Scope

New Zealand

High confidence

Status

published

SNZ editorial review

Evidence boundary: This record summarises the cited source. It does not establish local availability, individual eligibility, or professional advice.

Short Answer

Current Inland Revenue guidance for the 15% Research and Development Tax Incentive.

Key Points

  • •The incentive provides a 15% tax credit for eligible R&D expenditure.
  • •The standard annual minimum eligible expenditure is $50,000 unless approved-research-provider rules apply.
  • •The general maximum is $120 million of eligible expenditure without special approval.
  • •Eligibility depends on genuine systematic work to resolve scientific or technological uncertainty.
  • •PiP should obtain RDTI advice before relying on the credit or agreeing provider-funded IP terms.

Full Summary & Notes

Current Inland Revenue guidance for the 15% Research and Development Tax Incentive. It is a company-side tax mechanism for qualifying systematic technical experimentation, not upfront provider or health-service funding, and routine software construction or customer customisation is generally insufficient.

Document Details & Metadata

Related Resources

MD
High
2026 Office for Seniors - Web Capture - Digital Literacy Training for Seniors

The Office for Seniors delivered the Digital Literacy Training for Seniors programme from 2019.

6 indexed content areas
Office for Seniors2026
Funding & Finance
PDF
High
Young Company Finance - Autumn 2026

NZGCP's Autumn 2026 market report describes a strong headline year for New Zealand young-company investment with capital concentrated in later rounds and VC-led deals.

5 indexed content areas
New Zealand Growth Capital PartnersAutumn 2026
Funding & Finance
Brief
High
Home and Community Support versus Residential Care Cost Comparison

RNZ reports headline findings from a January 2024 Sapere analysis for Health NZ comparing public spending on subsidised residential care and home and community support.

5 indexed content areas
Sapere Research Group / RNZMarch 2026
Funding & Finance
PDF
High
2025 Angel Market Report

Angel Association New Zealand's 2025 report tracks activity by six active association groups using Catalist, together with co-investors alongside those groups.

5 indexed content areas
Angel Association New Zealand2026
Funding & Finance
Brief
High
Scout Fund and Aspire Seed Fund - Terms to Reconfirm

NZGCP's 2026-2030 Statement of Intent confirms a new Scout trial and planned annual allocation of $1 million-$2 million.

6 indexed content areas
New Zealand Growth Capital Partners2026
Funding & Finance
PDF
High
The Path to Profitability - Retirement Village Development Models

Sector-sponsored scenario modelling of village-development economics.

6 indexed content areas
Grant Thornton New ZealandJune 2025
Funding & Finance